Medical Advisory: Notice Regarding BAXJECT® II Reconstitution Devices
Takeda has brought to our attention an issue with some BAXJECT® II reconstitution devices produced between October 2021 and January 2022 for use in conjunction with RECOMBINATE [Antihemophilic [...]
